Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Hypertrophic cardiomyopathies and ATTR amyloidosis - a current review for clinical practice].

Deutsche medizinische Wochenschrift (1946) - 1 Sept 2022

Tschöpe Carsten, Elsanhoury Ahmed, Diekmann Sonja, Kühl Uwe

Abstract excerpt

Cardiomyopathies include dilated and restrictive cardiomyopathies as well as the various forms of hypertrophic cardiomyopathies (HCM). By definition, HCM is considered to occur when left ventricular wall thickness is ≥ 15 mm. This may be masked by genetic sarcomeric diseases, storage diseases, or syndromes. In clinical practice, sarcomere mutations and the cardiac amyloidoses are of particular interest because...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloidosis
Share to Cardiomyopathies
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Ventricles

Share to Mutation

Source

Identifiers

PMID: 36030786
DOI: 10.1055/a-1744-3126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Hypertrophic cardiomyopathies and ATTR amyloidosis - a current review for clinical practice].PMID 36030786Read ↗

[New guidelines on the diagnostic and therapeutic management of hypertrophic cardiomyopathy].Semantic proximity Read ↗

Hypertrophic Cardiomyopathies Phenocopies: Classification, Key Features and Differential DiagnosisSemantic proximity Read ↗

Hypertrophic Cardiomyopathy and Phenocopies: New Therapies for Old Diseases—Current Evidence and Future PerspectivesSemantic proximity Read ↗

Diagnostic clues for the diagnosis of nonsarcomeric hypertrophic cardiomyopathy (Phenocopies): Amyloidosis, fabry disease, and mitochondrial diseaseSemantic proximity Read ↗

[Guideline update: phenotype-based management of cardiomyopathy].Semantic proximity Read ↗

[Cardiomyopathies: a practical approach to the assessment and management of patients and their families].Semantic proximity Read ↗

From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow.Semantic proximity Read ↗

Classification, Epidemiology, and Global Burden of Cardiomyopathies.Semantic proximity Read ↗

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Almanac 2014: cardiomyopathies.Semantic proximity Read ↗

Diagnosis and management of inherited cardiomyopathies.Semantic proximity Read ↗

Hypertrophic Cardiomyopathy - A Heterogeneous and Lifelong Disease in the Real World.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.